Sales rise 7677.78% to Rs 7.00 crore
Net Loss of Bharat Immunological & Biological Corporation reported to Rs 3.46 crore in the quarter ended June 2019 as against net loss of Rs 0.83 crore during the previous quarter ended June 2018. Sales rose 7677.78% to Rs 7.00 crore in the quarter ended June 2019 as against Rs 0.09 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales7.000.09 7678 OPM %-82.00-1611.11 -PBDT-4.80-1.15 -317 PBT-5.00-1.25 -300 NP-3.46-0.83 -317Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
